BDBM335739 US9738641, 4::[1-(2-Phenyl-thiazol-4-ylmethyl)-1H-pyrrolo[3,2-c]pyridin-4-yl]-(1H-pyrrolo[2,3-b]pyridin-5-ylmethyl)-amine

SMILES C(Nc1nccc2n(Cc3csc(n3)-c3ccccc3)ccc12)c1cnc2[nH]ccc2c1

InChI Key InChIKey=ZQZFMVDDNFJRTA-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 335739   

TargetPlasma kallikrein(Human)
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM335739([1-(2-Phenyl-thiazol-4-ylmethyl)-1H-pyrrolo[3,2-c]...)
Affinity DataIC50: 5.32E+3nMAssay Description:Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
US Patent

TargetKallikrein-1(Human)
Kalvista Pharmaceuticals

US Patent
LigandPNGBDBM335739([1-(2-Phenyl-thiazol-4-ylmethyl)-1H-pyrrolo[3,2-c]...)
Affinity DataIC50: 1.03E+4nMAssay Description:KLK1 inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/1/2019
Entry Details
US Patent